The Immuno-Response to Primary Cryotherapy for the Treatment of Prostate Cancer
Sponsor: EDAP TMS S.A.
Listed as NCT02250014, this PHASE1 trial focuses on Recurrent Prostate Cancer and Stage I Prostate Cancer and remains completed. Sponsored by EDAP TMS S.A., it has been updated 13 times since 2015, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Mar 2022 — Jul 2024 [monthly]
Completed PHASE1
-
May 2021 — Mar 2022 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Jan 2021 — May 2021 [monthly]
Active Not Recruiting PHASE1
▶ Show 8 earlier versions
-
Apr 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1
-
Apr 2019 — Apr 2020 [monthly]
Active Not Recruiting PHASE1
-
Aug 2018 — Apr 2019 [monthly]
Active Not Recruiting PHASE1
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting PHASE1
-
Feb 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Jul 2017 — Feb 2018 [monthly]
Recruiting PHASE1
-
Feb 2017 — Jul 2017 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Oct 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- EDAP TMS S.A.
- University of Colorado, Denver
For direct contact, visit the study record on ClinicalTrials.gov .